Consistent with the dual effect of PPARγ to ameliorate insulin sensitivity while promoting fat differentiation, genetic studies have revealed that a partial loss-of-function Pro12Ala variant improved insulin sensitivity, while the gain-of-function Pro115Gln mutation was associated to obesity and insulin resistance in humans [110]. The gene discussed is INS; the disease is Insulin resistance.